Sunflower Pharmaceutical Group Co., Ltd. (SHE:002737)
China · Delayed Price · Currency is CNY 11.59
-0.11 (-0.94%)
Sep 10, 2026, 1:45 PM CST
SHE:002737 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 6,833 | 8,626 | 11,966 | 15,172 | 13,469 | 9,495 | |
Market Cap Growth | -26.42% | -27.92% | -21.13% | 12.65% | 41.85% | 11.35% |
Enterprise Value | 4,506 | 6,641 | 9,998 | 12,304 | 11,449 | 8,001 |
Last Close Price | 11.70 | 14.56 | 19.57 | 23.54 | 20.20 | 13.73 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 24.32 | 13.56 | 15.53 | 13.47 |
Forward PE | - | 10.63 | 10.63 | 10.63 | 10.63 | 10.63 |
PS Ratio | 2.73 | 3.72 | 3.54 | 2.66 | 2.64 | 2.13 |
PB Ratio | 1.68 | 2.16 | 2.61 | 3.03 | 3.03 | 2.41 |
P/TBV Ratio | 1.92 | 2.49 | 3.02 | 3.51 | 3.60 | 2.91 |
P/FCF Ratio | 54.74 | 18.01 | - | 20.49 | 7.39 | 12.71 |
P/OCF Ratio | 27.23 | 15.00 | - | 17.05 | 6.82 | 10.97 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.80 | 2.87 | 2.96 | 2.16 | 2.25 | 1.79 |
EV/EBITDA Ratio | - | - | 15.93 | 9.06 | 8.91 | 8.55 |
EV/EBIT Ratio | - | - | 22.08 | 10.40 | 11.20 | 10.37 |
EV/FCF Ratio | 36.10 | 13.87 | - | 16.62 | 6.28 | 10.71 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.05 | 0.03 | 0.00 | 0.01 | 0.10 | 0.06 |
Debt / EBITDA Ratio | - | - | 0.01 | 0.02 | 0.34 | 0.26 |
Debt / FCF Ratio | 1.54 | 0.24 | - | 0.04 | 0.24 | 0.33 |
Net Debt / Equity Ratio | -0.61 | -0.62 | -0.50 | -0.71 | -0.77 | -0.52 |
Net Debt / EBITDA Ratio | 22.61 | 19.75 | -3.65 | -2.63 | -2.65 | -2.19 |
Net Debt / FCF Ratio | -19.91 | -5.20 | 5.72 | -4.83 | -1.87 | -2.74 |
Asset Turnover | 0.46 | 0.42 | 0.53 | 0.82 | 0.80 | 0.83 |
Inventory Turnover | 1.95 | 1.98 | 2.18 | 3.31 | 3.22 | 2.87 |
Quick Ratio | 2.77 | 2.43 | 2.82 | 2.47 | 1.87 | 2.06 |
Current Ratio | 3.47 | 3.04 | 3.78 | 3.15 | 2.24 | 2.71 |
Return on Equity (ROE) | -6.70% | -6.92% | 10.48% | 24.67% | 21.73% | 20.81% |
Return on Assets (ROA) | -3.00% | -3.27% | 4.45% | 10.63% | 10.09% | 8.97% |
Return on Invested Capital (ROIC) | -16.90% | -15.35% | 19.24% | 82.86% | 59.06% | 34.70% |
Return on Capital Employed (ROCE) | -6.20% | -7.00% | 9.40% | 22.10% | 21.10% | 17.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -3.80% | -2.99% | 4.11% | 7.38% | 6.44% | 7.42% |
FCF Yield | 1.83% | 5.55% | -3.35% | 4.88% | 13.53% | 7.87% |
Dividend Yield | 1.70% | 1.37% | 2.56% | 6.37% | 4.95% | 5.10% |
Payout Ratio | - | - | 179.90% | 52.59% | 48.05% | 30.11% |
Buyback Yield / Dilution | 0.65% | -0.03% | -0.49% | 0.53% | -0.61% | 0.35% |
Total Shareholder Return | 2.35% | 1.34% | 2.06% | 6.90% | 4.34% | 5.44% |